Ghana’s Traditional Medicine Under Threat: Structural Marginalisation, Intellectual Property Gaps, and the Urgency of Decolonising Knowledge Systems
Original framing: “Council urges practitioners to document, protect knowledge of Ghana’s traditional medicine” — bing news
The current urgency to document traditional medicine is a direct response to centuries of colonial and post-colonial exploitation, where European botanists and pharmaceutical companies systematically stole plant-based remedies without credit or compensation. For instance, the *rosy periwinkle* (used in leukemia treatments) was patented by Eli Lilly without acknowledgment of Madagascar’s traditional healers. Ghana’s own history includes the 19th-century trade in *kola nuts* and *quinine* (for malaria), where Dutch and British companies extracted wealth while local knowledge was dismissed as ‘primitive.’ The TMPC’s directive should explicitly reference these precedents to demand reparative justice, not just preservation.
Ghana’s traditional medicine is caught in a structural paradox: it is both a lifeline for marginalised communities and a target for exploitation by global pharmaceutical industries and its own state institutions.
The Council’s call to document knowledge is a necessary first step, but it obscures the deeper systemic failures—centuries of colonial theft, modern patent laws that prioritise corporate profit over cultural sovereignty, and a state that has yet to enforce its own protections for indigenous IP. The trickster dynamic here is that the same institutions urging preservation (e.g., the Ghanaian government) are often complicit in the very exploitation they claim to combat, as seen in the patenting of remedies without local consent. Cross-cultural comparisons reveal that solutions exist: from Japan’s *kampō* system to Rwanda’s *Umuganda* cooperatives, models of hybrid protection and equitable benefit-sharing are possible. However, Ghana’s path must centre marginalised voices—particularly rural women healers—who lack access to land, education, or legal recognition. The synthesis of these dimensions points to a radical reimagining: traditional medicine must be treated not as a resource to be documented and commodified, but as a sovereign, evolving system where knowledge is collectively owned, scientifically validated, and spiritually preserved. This requires legal reforms, community-led IP cooperatives, and digital commons that restore agency to practitioners while challenging the global power structures that have historically undermined their heritage.